Digostics

About

50% of adults living with diabetes remain undiagnosed. Given the significant population health implications of missed or delayed detection, an immediate step-change is required in how we test for diabetes. Digostics offers the world's first and only alternative to in-clinic oral glucose tolerance testing (OGTT) by enabling this crucial diabetes test to be performed at home. Simplified testing. Increased patient throughput. Better outcomes.